BIIB Biogen Inc

By Colin Kellaher

Biogen Inc. (BIIB) on Tuesday said Michael Ehlers is stepping down as executive vice president of research and development to pursue a new opportunity.

The Cambridge, Mass., biopharmaceutical company said Chief Medical Officer Alfred Sandrock Jr. will assume the additional post of executive vice president of research and development, and said it named Alphonse Galdes executive vice president of pharmaceutical operations and technology.

Mr. Ehlers has been head of R&D at Biogen since joining from Pfizer Inc. (PFE) in 2016.

Mr. Sandrock, who joined Biogen in 1998, has been chief medical officer since 2012 and a member of the company's executive committee since 2015.

Mr. Galdes, who joining Biogen in 1995, had been serving as senior vice president of asset development and portfolio management.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

October 01, 2019 08:44 ET (12:44 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.